SCHEMBL10099657

SCHEMBL10099657

CC(C)[Si](Oc1ccc(O)c(C(C)(C)C)c1)(C(C)C)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
ESRRA P11474 5/20 0.48
ALOX15 P16050 2/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 1/20 0.47
MIF P14174 1/20 0.47
TYR P14679 1/20 0.47
HTT P42858 1/20 0.47
NFE2L2 Q16236 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GAA P10253 2/20 0.47
NR1H4 Q96RI1 6/20 0.44
ATM Q13315 2/20 0.44
XBP1 P17861 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23036593 0.81 TDP1 (0.42) ALDH1A1ALOX15CYP2C9HSD17B10NPSR1
SCHEMBL5735681 0.80 ALDH1A1 (0.31) ALDH1A1
SCHEMBL30490014 0.78 ALDH1A1 (0.53) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL7204289 0.76 ESRRA (0.72) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL35535 0.74 ALDH1A1 (0.73) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL29362042 0.74 ALDH1A1 (0.73) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL6142004 0.74 ALDH1A1 (0.73) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL9008266 0.74 ESRRA (0.59) ALDH1A1ESRRAALOX15NR1I2LMNA
SCHEMBL5737701 0.73 CA12 (0.40) ALDH1A1HSD17B10GAANR1H4ATM
SCHEMBL5737146 0.73 GAA (0.32) ALDH1A1GAAATMXBP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207365-B2 Polymeric salen compounds and methods thereof GEORGIA TECH RESEARCH CORPORATION (US) 2012-06-26 US disclosed
US-20090030172-A1 POLYMERIC SALEN COMPOUNDS AND METHODS THEREOF GEORGIA TECH RESEARCH CORPORATION (US) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030172-A1 POLYMERIC SALEN COMPOUNDS AND METHODS THEREOF F12, CHRM1, H1-0 ALDH1A1 1087/4885ESRRA 1852/4885ALOX15 4056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.